evidencegaps
Primary study · included by 1 review

Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study).

Yang 2024 · Yang Yingnan, Zhang Jinfeng, Meng Hongxue, et al. · International journal of surgery (London, England) · 2024

Included by

The Efficacy and Safety of Neoadjuvant Immunotherapy in Pan-Squamous Cell Carcinomas: A Meta-Analysis of Esophageal, Head and Neck, Cervical, Lung, Cutaneous, and Oral Squamous Cell Carcinomas.
Non-Cochrane · intervention · 2026 · cited as Yang 2024 · Supplementary Table S1; reference list

The review does not say which of its outcomes this study informs.

1 including review in total.